Send feedback

BAAT p.Val137Ile

c.409G>A · rs144591246 · VCV289597

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.1068 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.275%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
hypercholanemia, familial 1

Computational evidence

Protein change
AlphaMissense0.1068likely benign
REVEL0.395indeterminate
SaProtLLR -8.87tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.52GERP 1.7, phastCons 0.038
Regional constrainto/e 0.97unconstrained · MANE · 8,973 bp · p 0.5 · regional, not allelic
Overall
CADD19.59PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.275% European (non-Finnish) · 3,240/1,180,012 alleles
Filtering AF 0.267% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.263%
Overall 0.235% 3,794/1,614,132 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.672% 149
European (non-Finnish)grpmax 0.275% 364
Finnishnot grpmax-eligible 0.27% 370
Remaining individualsnot grpmax-eligible 0.206% 485
Admixed American 0.055% 1,818
Middle Eastern 0.0495% 2,020
African / African-American 0.0213% 4,691
South Asian 0.0011% 91,082

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BAAT
Protein
p.Val137Ile
Coding
c.409G>A
MANE Select
NM_001701
dbSNP
rs144591246
Type
single nucleotide variant
Location
chr9:101370996 (GRCh38)
Gene constraint
LOEUF 1.049 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 95.31
Residue 137
a UniProt-annotated variant site (in fhca3; contrary to wild-type, undetectable expression in hepatocytes)
Full BAAT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hypercholanemia, familial 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Familial hypercholanemia (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/baat-p-val137ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown